Recent advances in sleep and depression - PubMed (original) (raw)

Review

. 2023 Jan 1;36(1):34-40.

doi: 10.1097/YCO.0000000000000837. Epub 2022 Nov 16.

Affiliations

Review

Recent advances in sleep and depression

Riya Mirchandaney et al. Curr Opin Psychiatry. 2023.

Abstract

Purpose of review: There is increasing interest in the connection between sleep disturbances and mood disorders. The purpose of this review is to summarize and evaluate current research on the role of sleep disturbance in the development of depression, as well as to describe recent advances in treatments that improve both sleep and depression symptoms.

Recent findings: Relevant publications included in this review cover a wide range of topics related to sleep and depression. Data from large longitudinal studies suggest that insomnia and evening circadian preference are unique risk factors for depression. Depression treatment studies indicate poorer outcomes for those with comorbid sleep disturbances. A few recent trials of cognitive behavioral therapy for insomnia and triple chronotherapy in unipolar depression have shown promising results.

Summary: Sleep disturbance is a modifiable risk factor in the development and maintenance of depression. In the context of current depression, although the data is mixed, some evidence suggests treating sleep disturbance can improve overall outcomes. Recent evidence also suggests that treating sleep disturbance may prevent the future depressive episodes.

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

PubMed Disclaimer

References

    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). USA: American Psychiatric Publication; 2013.
    1. Services USDoHH: 2020 National Survey of Drug Use and Health (NSDUH) Releases. Available at: https://www.samhsa.gov/data/release/2020-national-survey-drug-use-and-he... (2020). [Accessed 12 September 2022]
    1. Ettman CK, Abdalla SM, Cohen GH, et al. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open 2020; 3: e2019686.
    1. Stewart R, Besset A, Bebbington P, et al. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep 2006; 29:1391–1397.
    1. Soehner AM, Kaplan KA, Harvey AG. Prevalence and clinical correlates of co-occurring insomnia and hypersomnia symptoms in depression. J Affect Disord 2014; 167:93–97.

Publication types

MeSH terms

LinkOut - more resources